Source: DGNews | Posted 8 years ago
European Union Approves Remicade (Infliximab) For Treatment Of Ankylosing Spondylitis
Tags:
First and Only Anti-TNF Agent Approved for Treatment Of This Chronic, Debilitating Inflammatory Disease of the Spinal Column
KENILWORTH, NJ -- May 21, 2003 -- Schering-Plough Corporation (NYSE: SGP) today announced that the European Commission of the European Union (EU) has granted centralized marketing authorization to Remicade
Comments